PR Newswire
London, July 9
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Sutherland Health Group Plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | Part-conversion of Loan Note into Ordinary shares | x | ||
| 3. Full name of person(s) subject to the notification obligation: iii | Webb Capital Asset Management Limited | |||
| 4. Full name of shareholder(s) (if different from 3.):iv | Nortrust Nominees Limited a/c Elite Webb Capital Smaller Companies Income and Growth Fund BNP Paribas Securities Services (Harewood Nominees ) a/c SF Webb Capital Smaller Companies Growth Fund | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 07/07/2015 | |||
| 6. Date on which issuer notified: | 08/07/2015 | |||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 3,4,5,6,7,8,9,10% | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Ordinary 0.2p | 2,171,428 | 2,171,428 | 8,838,095 | 8,838,095 | 10.42% | |||||||||||
| GB00B04QRJ18 | ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 8,838,095 | 10.42% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
SF Webb Capital Smaller Companies Growth Fund (2.56%) Elite Webb Capital Smaller Companies Income & Growth Fund (7.86%) | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: | ||
| 12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | ||
| 14. Contact name: | Peter Webb | |
| 15. Contact telephone number: | 020 7634 9510 | |
© 2015 PR Newswire
